Literature DB >> 1550780

Promoter mutations producing mild beta-thalassaemia in the Italian population.

A Meloni1, M C Rosatelli, V Faà, R Sardu, L Saba, S Murru, G V Sciarratta, M Baldi, N Tannoia, A Vitucci.   

Abstract

In this study we have investigated the molecular basis for a mild form of beta-thalassaemia in three patients of Italian descent. In two, belonging to different families and affected by a mild and late-presenting form of thalassaemia major, direct sequencing of amplified DNA detected a C----T substitution at position -87 of the beta-globin gene in the compound heterozygous state either with codon 39 nonsense mutation or beta +IVSI, nt 110 mutation. The -87 (C----T) mutation has been previously described, in combination with the beta +IVSI, nt 110 mutation, in a single patient with thalassaemia intermedia. Both our patients showed a more severe phenotype as compared to that resulting from compound heterozygosity for a severe beta-thalassaemia mutation and another promoter mutation (-87, C----G) at the same position. In the third patient with the thalassaemia intermedia phenotype, we detected a novel promoter mutation, consisting in a C----A substitution at position -86, in combination with the codon 39 nonsense mutation. The results of this study indicate that different nucleotide substitutions affecting the proximal CACCC box of the beta-globin gene in combination with severe beta-thalassaemia, produce a mild form of thalassaemia ranging in severity from thalassaemia intermedia to late-presenting thalassaemia major.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1550780     DOI: 10.1111/j.1365-2141.1992.tb08904.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Role of the liver-enriched transcription factor hepatocyte nuclear factor 1 in transcriptional regulation of the factor V111 gene.

Authors:  L K McGlynn; C R Mueller; M Begbie; C R Notley; D Lillicrap
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

2.  Scanning of beta-globin gene for identification of beta-thalassemia mutation in Romanian population.

Authors:  R Talmaci; J Traeger-Synodinos; E Kanavakis; D Coriu; D Colita; L Gavrila
Journal:  J Cell Mol Med       Date:  2004 Apr-Jun       Impact factor: 5.310

3.  Absence of mutations in the promoter of the COL1A1 gene of type I collagen in patients with osteogenesis imperfecta type I.

Authors:  M C Willing; R L Slayton; S H Pitts; S P Deschenes
Journal:  J Med Genet       Date:  1995-09       Impact factor: 6.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.